Tonga Healthcare Daily
SEE OTHER BRANDS

Informing on health and wellness news in Tonga

Tonga Healthcare Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tonga Healthcare Daily.

Press releases published on August 15, 2025

EAACI lança campanha global de conscientização sobre alergia a antibióticos no Congresso EAACI 2025 (EAACI Congress 2025)

EAACI lança campanha global de conscientização sobre alergia a antibióticos no Congresso EAACI 2025 (EAACI Congress 2025)

ZURIQUE, Aug. 15, 2025 (GLOBE NEWSWIRE) -- A EAACI lançou sua Campanha de Conscientização sobre Alergia a Antibióticos durante seu Congresso de 2025, realizado em Glasgow. A iniciativa dá início a um esforço global para abordar a rotulagem incorreta e sua …

EAACI เปิดตัวแคมเปญระดับโลกเพื่อเพิ่มความตระหนักเกี่ยวกับอาการแพ้ยาปฏิชีวนะในงานประชุม EAACI 2025 (EAACI Congress 2025…

EAACI เปิดตัวแคมเปญระดับโลกเพื่อเพิ่มความตระหนักเกี่ยวกับอาการแพ้ยาปฏิชีวนะในงานประชุม EAACI 2025 (EAACI Congress 2025…

ซูริค, Aug. 15, 2025 (GLOBE NEWSWIRE) -- EAACI ได้เปิดตัวแคมเปญสร้างความตระหนักเกี่ยวกับอาการแพ้ยาปฏิชีวนะในระหว่างการประชุม EAACI 2025 ที่เมืองกลาสโกว์ โครงการนี้เริ่มต้นความพยายามระดับโลกในการแก้ไขปัญหาการติดฉลากผิดและความเชื่อมโยงกับการดื้อยาต้านจุลชีพ …

EAACI 在 EAACI 2025 年大会 (EAACI Congress 2025) 上启动全球抗生素过敏意识宣传活动

EAACI 在 EAACI 2025 年大会 (EAACI Congress 2025) 上启动全球抗生素过敏意识宣传活动

苏黎世, Aug. 15, 2025 (GLOBE NEWSWIRE) -- EAACI 在其 2025 年格拉斯哥大会期间启动了抗生素过敏意识宣传活动。 这一倡议开启了一项全球行动,旨在解决误标问题及其与抗菌素耐药性 (AMR) 的关联。 全球行动号召 抗生素过敏误标影响全球数百万人。 不准确的标注导致人们回避一线治疗,并过度使用二线抗生素,从而加剧了 AMR。 EAACI 呼吁所有利益相关者推动准确诊断和负责任地使用抗生素。 “我们正在发起一场运动——而非一时之举,”EAACI 主席 Maria …

EAACI Launches Global Antibiotic Allergy Awareness Campaign at EAACI Congress 2025

EAACI Launches Global Antibiotic Allergy Awareness Campaign at EAACI Congress 2025

ZURICH, Aug. 15, 2025 (GLOBE NEWSWIRE) -- EAACI has launched its Antibiotic Allergy Awareness Campaign during its 2025 Congress in Glasgow. The initiative begins a global effort to address mislabelling and its link to antimicrobial resistance (AMR). A …

EAACI 於 2025 年 EAACI 大會 (EAACI Congress 2025)上啟動全球抗生素過敏意識宣傳活動

EAACI 於 2025 年 EAACI 大會 (EAACI Congress 2025)上啟動全球抗生素過敏意識宣傳活動

蘇黎世, Aug. 15, 2025 (GLOBE NEWSWIRE) -- EAACI 於格拉斯哥舉行的 2025 年度大會上啟動了抗生素過敏意識宣傳活動。 此倡議開創了一項全球行動,以解決錯誤標籤問題及其與抗微生物劑耐藥性 (AMR) 的關聯。 全球行動呼籲 抗生素過敏錯誤標籤影響全球數百萬人。 若因標籤不準確,導致不採用一線治療方式而過度使用二線抗生素,這會加劇 AMR 的情況。 EAACI 呼籲所有持份者推動準確診斷和負責任地使用抗生素。 EAACI 主席 Maria Torres …

Santhera verlängert Wandelanleihe von Highbridge bis zum 30. September 2025

Santhera verlängert Wandelanleihe von Highbridge bis zum 30. September 2025

Ad hoc-Mitteilung gemäss Art. 53 KR Pratteln, Schweiz, 15. August 2025 – Santhera Pharmaceuticals (SIX: SANN) gibt bekannt, dass das Unternehmen und Highbridge Capital Management, LLC (Highbridge) einvernehmlich beschlossen haben, die Laufzeit der …

Santhera extends Highbridge convertible bond to 30th September 2025

Santhera extends Highbridge convertible bond to 30th September 2025

Ad hoc announcement pursuant to Art. 53 LRA Pratteln, Switzerland, 15 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces that by mutual agreement the Company and Highbridge Capital Management, LLC (Highbridge) have decided to extend the maturity …

Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering

Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering

MELBOURNE, Australia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today …

24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025

24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025

Breakthrough Protein Phosphatase 2A inhibitor LB-100 Targets Ovarian Clear Cell Carcinoma, Advanced Soft Tissue Sarcoma, and MSS Metastatic Colon Cancer 24/7 Market News Issues Corrected Information on Previously issued Press Release with same title DENVER …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions